Report
Jake Strole
EUR 101.80 For Business Accounts Only

Initiating Coverage of Getinge AB With SEK 136 Fair Value Estimate, No Moat, and Negative Trend

We are initiating coverage of Getinge AB, a Sweden-based supplier of medical equipment to hospitals on a worldwide basis, with no moat and negative trend ratings. Our estimate of fair value puts Getinge shares at SEK 136, and we view the stock as slightly overvalued.
Our primary concerns stem from ongoing quality issues that came to a boiling point with the FDA back in 2015, relating to multiple inspection violations in prior years. The firm has been working to re-establish FDA compliance at a h...
Underlying
Getinge AB Class B

Getinge is engaged in three business areas: Medical Systems, Extended Care and Infection Control. Medical System's product range includes surgical tables, surgical lamps, telemedicine, perfusion products, instruments for bypass operations, ventilators, anesthesia systems, synthetic vascular implants and stents. Extended Care's product range includes bathing and shower solutions, lifting equipment and mattresses for the treatment and prevention of pressure ulcers, as well as service and consulting. Infection Control's product range comprises disinfectors, sterilizers, information technology systems and related equipment, as well as service and consulting.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Jake Strole

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch